logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Haque, Kemal, Dr
    Born in April 1969
    Individual (3 offsprings)
    Officer
    2019-10-22 ~ now
    OF - Director → CIF 0
    Dr Kemal Haque
    Born in April 1969
    Individual (3 offsprings)
    Person with significant control
    2019-10-22 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Sparksman, Caitlin
    Born in April 1971
    Individual (1 offspring)
    Officer
    2019-10-22 ~ now
    OF - Director → CIF 0
    Mrs Caitlin Sparksman
    Born in April 1971
    Individual (1 offspring)
    Person with significant control
    2019-10-22 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

OKTEM BIOPHARMA CONSULTING LTD

Period: 2019-10-22 ~ now
Company number: 12274031
Registered name
OKTEM BIOPHARMA CONSULTING LTD - now
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
22023-11-01 ~ 2024-10-31
22022-11-01 ~ 2023-10-31
Property, Plant & Equipment
260 GBP2024-10-31
519 GBP2023-10-31
Debtors
Current
9,027 GBP2024-10-31
8,461 GBP2023-10-31
Cash at bank and in hand
57,289 GBP2024-10-31
70,523 GBP2023-10-31
Current Assets
66,316 GBP2024-10-31
78,984 GBP2023-10-31
Creditors
Current, Amounts falling due within one year
-16,627 GBP2024-10-31
Net Current Assets/Liabilities
49,689 GBP2024-10-31
63,970 GBP2023-10-31
Total Assets Less Current Liabilities
49,949 GBP2024-10-31
64,489 GBP2023-10-31
Net Assets/Liabilities
49,884 GBP2024-10-31
64,359 GBP2023-10-31
Equity
Called up share capital
2 GBP2024-10-31
2 GBP2023-10-31
Retained earnings (accumulated losses)
49,882 GBP2024-10-31
64,357 GBP2023-10-31
Equity
49,884 GBP2024-10-31
64,359 GBP2023-10-31
Property, Plant & Equipment - Depreciation rate used
Office equipment
332023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Gross Cost
Other
3,396 GBP2024-10-31
3,134 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
3,136 GBP2024-10-31
Property, Plant & Equipment
Other
260 GBP2024-10-31
519 GBP2023-10-31
Trade Debtors/Trade Receivables
Current
8,687 GBP2024-10-31
8,188 GBP2023-10-31
Prepayments/Accrued Income
Current
340 GBP2024-10-31
273 GBP2023-10-31
Corporation Tax Payable
Current
5,982 GBP2024-10-31
4,168 GBP2023-10-31
Taxation/Social Security Payable
Current
1,133 GBP2024-10-31
1,334 GBP2023-10-31
Accrued Liabilities/Deferred Income
Current
9,512 GBP2024-10-31
9,512 GBP2023-10-31
Creditors
Current
16,627 GBP2024-10-31
15,014 GBP2023-10-31
Net Deferred Tax Liability/Asset
-65 GBP2024-10-31
-130 GBP2023-10-31
-167 GBP2022-11-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
65 GBP2023-11-01 ~ 2024-10-31
37 GBP2022-11-01 ~ 2023-10-31
Deferred Tax Liabilities
Accelerated tax depreciation
-65 GBP2024-10-31
-130 GBP2023-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2024-10-31
2 shares2023-10-31
Par Value of Share
Class 1 ordinary share
1.002023-11-01 ~ 2024-10-31

  • OKTEM BIOPHARMA CONSULTING LTD
    Info
    Registered number 12274031
    Tennyson House, Cambridge Business Park, Cambridge CB4 0WZ
    PRIVATE LIMITED COMPANY incorporated on 2019-10-22 (6 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-21
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.